The global biosimilars market, which was valued at $5.5 billion in 2018, is estimated to grow at a CAGR of 38.21% during the forecast period of 2019 to 2025.

Biosimilars are alternatives to existing biological medicines. Since biological medicines are expensive for certain sections of the population, the biosimilar vertical in the pharmaceuticals industry is gaining popularity.